ACADIA Pharmaceuticals Inc. (ACAD)

ACADIA Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	2,972	5,140	2,578	3,752	8,499	6,589
Market Cap Growth	-0.21%	99.40%	-31.29%	-55.85%	28.98%	225.80%
Enterprise Value	2,506	4,744	2,208	3,282	7,906	5,893
PE Ratio	-	-83.88	-11.94	-22.35	-30.18	-28.01
PS Ratio	3.60	7.08	4.98	7.75	19.24	19.43
PB Ratio	6.32	11.91	6.44	6.94	13.56	9.43
P/FCF Ratio	46.06	308.70	-22.61	-29.59	-59.12	-43.28
P/OCF Ratio	46.03	307.78	-22.61	-29.86	-62.42	-43.60
EV/Sales Ratio	3.08	6.53	4.27	6.78	17.90	17.38
EV/EBITDA Ratio	98.03	-104.29	-10.44	-19.99	-28.43	-25.44
EV/EBIT Ratio	168.10	-92.95	-10.34	-19.59	-28.14	-25.14
EV/FCF Ratio	39.36	284.87	-19.36	-25.88	-55.00	-38.71
Debt / Equity Ratio	0.11	0.11	0.13	0.10	0.07	0.01
Debt / EBITDA Ratio	1.92	-1.05	-0.25	-0.34	-0.16	-0.03
Debt / FCF Ratio	0.77	2.87	-0.46	-0.44	-0.31	-0.04
Quick Ratio	1.74	2.15	3.87	6.16	6.49	9.89
Current Ratio	2.04	2.42	4.04	6.43	6.77	10.16
Asset Turnover	1.13	1.08	0.85	0.67	0.57	0.54
Return on Equity (ROE)	-0.40%	-15.70%	-50.60%	-29.80%	-43.60%	-42.90%
Return on Assets (ROA)	-0.20%	-9.10%	-35.60%	-23.20%	-36.50%	-37.50%
Return on Capital (ROIC)	0.10%	-15.30%	-49.35%	-28.55%	-42.68%	-34.95%
Earnings Yield	-0.06%	-1.19%	-8.38%	-4.47%	-3.31%	-3.57%
FCF Yield	2.17%	0.32%	-4.42%	-3.38%	-1.69%	-2.31%
Buyback Yield / Dilution	-2.69%	-1.32%	-0.74%	-2.01%	-6.88%	-16.29%
Total Shareholder Return	-2.69%	-1.32%	-0.74%	-2.01%	-6.88%	-16.29%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).